VEGF receptor expression and signaling in human bladder tumors

被引:129
作者
Wu, WC [1 ]
Shu, XD [1 ]
Hovsepyan, H [1 ]
Mosteller, RD [1 ]
Broek, D [1 ]
机构
[1] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA
关键词
VEGF; sphingosine kinase; bladder tumor;
D O I
10.1038/sj.onc.1206285
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Overexpression of vascular endothelial growth factor receptors (VEGFRs) has been reported in a variety of tumor types. Here we find that 11 out of the 14 bladder tumor cell tines examined express one or more VEGF receptors. Analysis of the T24 bladder tumor cell line reveals a functional autocrine loop involving VEGF and the Flk-1 receptor. Blocking VEGF expression in T24 cells results in a decrease in DNA synthesis. The Flk-1 receptor in T24 cells is phosphorylated in response to VEGF-121 or VEGF-165, and an Flk-1 inhibitor blocks VEGF to ERK signaling. We report that VEGF stimulation of T24 cells results in activation of H- and N-Ras and this is dependent on cellular sphingosine kinase I (SPK1) activity. Previously, we found VEGF-induced activation of Ras appears to be independent of a Ras-guanine nucleotide exchange factors (GEFs). Here we report that sphingosine can stimulate Ras-GTPase activating protein (GAP) activity in vitro, and sphingosine-I-phosphate (SPP) can block the stimulatory effects of sphingosine. We present a model where the balance between sphingosine and SPP regulates Ras-GAP activity such that stimulation of SPK1 favors downregulation of Ras-GAP and thereby the activation of Ras proteins. These data highlight a VEGF pathway that may be involved in the survival and proliferation of bladder tumor cells as well as other tumor cell types.
引用
收藏
页码:3361 / 3370
页数:10
相关论文
共 36 条
[1]   DIFFERENTIAL REGULATION OF RASGAP AND NEUROFIBROMATOSIS GENE-PRODUCT ACTIVITIES [J].
BOLLAG, G ;
MCCORMICK, F .
NATURE, 1991, 351 (6327) :576-579
[2]  
BOLLAG G, 1995, METHOD ENZYMOL, V255, P161
[3]  
BROWN LF, 1993, AM J PATHOL, V143, P1255
[4]   A mechanism for modulation of cellular responses to VEGF: Activation of the integrins [J].
Byzova, TV ;
Goldman, CK ;
Pampori, N ;
Thomas, KA ;
Bett, A ;
Shattil, SJ ;
Plow, EF .
MOLECULAR CELL, 2000, 6 (04) :851-860
[5]  
Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249
[6]  
Crew JP, 1997, CANCER RES, V57, P5281
[7]   Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration [J].
Dias, S ;
Hattori, K ;
Zhu, ZP ;
Heissig, B ;
Choy, M ;
Lane, W ;
Wu, Y ;
Chadburn, A ;
Hyjek, E ;
Gill, M ;
Hicklin, DJ ;
Witte, L ;
Moore, MAS ;
Rafii, S .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (04) :511-521
[8]   N,N-dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C:: Modulation of cellular levels of sphingosine 1-phosphate and ceramide [J].
Edsall, LC ;
Van Brocklyn, JR ;
Cuvillier, O ;
Kleuser, B ;
Spiegel, S .
BIOCHEMISTRY, 1998, 37 (37) :12892-12898
[9]   Molecular and biological properties of vascular endothelial growth factor [J].
Ferrara, N .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (07) :527-543
[10]   Expression of vascular endothelial growth factor receptors in human prostate cancer [J].
Ferrer, FA ;
Miller, LJ ;
Lindquist, R ;
Kowalczyk, P ;
Laudone, VP ;
Albertsen, PC ;
Kreutzer, DL .
UROLOGY, 1999, 54 (03) :567-572